Disposition kinetics of dibekacin in patients with renal failure and in patients undergoing hemodialysis
Author
dc.contributor.author
Arancibia, Verónica
Author
dc.contributor.author
Baillarie,
Author
dc.contributor.author
Bravo, Roberto
Author
dc.contributor.author
Chavez,
Admission date
dc.date.accessioned
2019-01-29T15:50:07Z
Available date
dc.date.available
2019-01-29T15:50:07Z
Publication date
dc.date.issued
1995
Cita de ítem
dc.identifier.citation
International Journal of Clinical Pharmacology and Therapeutics, Volumen 33, Issue 11, 2018, Pages 623-627
Identifier
dc.identifier.issn
09461965
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/162559
Abstract
dc.description.abstract
Dibekacin pharmacokinetics was studied in 3 healthy volunteers, 5 patients with renal failure presenting Cl(cr), between 4.0 and 67 ml min-1 per 1.73 m2 of body surface and 5 anephric patients given as a 30 minute intravenous infusion. The antibiotic was assayed in plasma and urine by means of a high performance liquid chromatography (HPLC) method. A two compartment kinetic model was used to describe the bi-phasic decline of plasma concentration and to calculate the different pharmacokinetic parameters. Slow disposition and elimination rate constants β and k10 respectively, and total body clearance were markedly diminished in anephric patients (p << 0.001): t1/2β = 2.12 h, k10 = 0.642 h-1 and Cl = 0.882 ml/min per kg, in normal subjects and t1/2β = 4.73 h, k10 = 0.278 h-1 and Cl = 0.693 ml/min per kg in anephric patients. The apparent volumes of distribution increased while the creatinine clearance of the patients decreased. Thus Vd((area)) of volunteers with normal renal function was